11-32388003-AACACACACACACACACACAC-AACACACACACACACACACACAC

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2

The NM_024426.6(WT1):​c.*1053_*1054dupGT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.040 ( 119 hom., cov: 0)
Exomes 𝑓: 0.037 ( 0 hom. )

Consequence

WT1
NM_024426.6 3_prime_UTR

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:9

Conservation

PhyloP100: 1.29

Publications

2 publications found
Variant links:
Genes affected
WT1 (HGNC:12796): (WT1 transcription factor) This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015]
WT1 Gene-Disease associations (from GenCC):
  • Denys-Drash syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, G2P
  • Wilms tumor 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Frasier syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0398 (5828/146512) while in subpopulation AMR AF = 0.0513 (754/14702). AF 95% confidence interval is 0.0483. There are 119 homozygotes in GnomAd4. There are 2694 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 5828 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WT1NM_024426.6 linkc.*1053_*1054dupGT 3_prime_UTR_variant Exon 10 of 10 ENST00000452863.10 NP_077744.4 P19544-7Q6PI38

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WT1ENST00000452863.10 linkc.*1053_*1054dupGT 3_prime_UTR_variant Exon 10 of 10 1 NM_024426.6 ENSP00000415516.5 P19544-7A0A0A0MT54

Frequencies

GnomAD3 genomes
AF:
0.0397
AC:
5819
AN:
146396
Hom.:
119
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0389
Gnomad AMI
AF:
0.120
Gnomad AMR
AF:
0.0513
Gnomad ASJ
AF:
0.0209
Gnomad EAS
AF:
0.0241
Gnomad SAS
AF:
0.0188
Gnomad FIN
AF:
0.0213
Gnomad MID
AF:
0.0288
Gnomad NFE
AF:
0.0426
Gnomad OTH
AF:
0.0499
GnomAD4 exome
AF:
0.0371
AC:
3052
AN:
82374
Hom.:
0
Cov.:
0
AF XY:
0.0370
AC XY:
1406
AN XY:
38014
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0376
AC:
146
AN:
3884
American (AMR)
AF:
0.0443
AC:
111
AN:
2504
Ashkenazi Jewish (ASJ)
AF:
0.0149
AC:
76
AN:
5110
East Asian (EAS)
AF:
0.0483
AC:
554
AN:
11474
South Asian (SAS)
AF:
0.0101
AC:
7
AN:
696
European-Finnish (FIN)
AF:
0.0173
AC:
13
AN:
750
Middle Eastern (MID)
AF:
0.0328
AC:
16
AN:
488
European-Non Finnish (NFE)
AF:
0.0373
AC:
1892
AN:
50680
Other (OTH)
AF:
0.0349
AC:
237
AN:
6788
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.327
Heterozygous variant carriers
0
203
405
608
810
1013
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0398
AC:
5828
AN:
146512
Hom.:
119
Cov.:
0
AF XY:
0.0378
AC XY:
2694
AN XY:
71250
show subpopulations
African (AFR)
AF:
0.0390
AC:
1569
AN:
40212
American (AMR)
AF:
0.0513
AC:
754
AN:
14702
Ashkenazi Jewish (ASJ)
AF:
0.0209
AC:
71
AN:
3390
East Asian (EAS)
AF:
0.0243
AC:
121
AN:
4972
South Asian (SAS)
AF:
0.0191
AC:
87
AN:
4560
European-Finnish (FIN)
AF:
0.0213
AC:
204
AN:
9572
Middle Eastern (MID)
AF:
0.0278
AC:
8
AN:
288
European-Non Finnish (NFE)
AF:
0.0426
AC:
2808
AN:
65904
Other (OTH)
AF:
0.0493
AC:
100
AN:
2028
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
254
509
763
1018
1272
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0190
Hom.:
53

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Nephroblastoma Uncertain:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

11p partial monosomy syndrome Uncertain:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Meacham syndrome Uncertain:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephrotic syndrome, type 4 Uncertain:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.3
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58549495; hg19: chr11-32409549; API